All stocks ยท VENMAX
VD

Venmax Drugs And Pharmaceuticals Ltd

VENMAX BSE Drug Manufacturers - Specialty & Generic Healthcare

Venmax Drugs and Pharmaceuticals Limited engages in the business of pharmaceutical products, drug intermediaries, and API's. The company was formerly known as Yenkey Drugs & Pharmaceuticals Ltd and changed its name to Vโ€ฆ

ISIN INE154G01022
Listed โ€”
Quarters tracked 13
Filings 19 docs

About

Venmax Drugs and Pharmaceuticals Limited engages in the business of pharmaceutical products, drug intermediaries, and API's. The company was formerly known as Yenkey Drugs & Pharmaceuticals Ltd and changed its name to Venmax Drugs and Pharmaceuticals Limited in April 2009. Venmax Drugs and Pharmaceuticals Limited was incorporated in 1988 and is based in Hyderabad, India.

Key Metrics

as of Sep 2026
Market Cap23 Cr
P/E82.10
Div Yield0.00 %
Book Valueโ‚น13.00
52w Highโ‚น31.50
52w Lowโ‚น13.50
Face Valueโ‚น10.00

Quarterly Results

Rs. Crores ยท hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 2.48 3.94 1.55 1.32 1.21 0.33 0.20 0.17 0.10 0.00 0.00 0.00 0.00
Expenses 2.36 3.92 1.58 1.27 1.17 0.57 0.69 0.47 0.12 0.04 0.01 0.03 0.03
Operating Profit 0.12 0.02 -0.03 0.05 0.04 -0.24 -0.49 -0.30 -0.02 -0.04 -0.01 -0.03 -0.03
OPM % 4.84 0.51 -1.94 3.79 3.31 -72.73 -245.00 -176.47 -20.00 โ€” โ€” โ€” โ€”
Other Income 0.00 0.09 0.07 0.00 0.00 1.02 0.00 0.00 0.03 0.10 0.05 0.00 0.05
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Profit before tax 0.12 0.11 0.04 0.05 0.04 0.78 -0.49 -0.30 0.01 0.06 0.04 -0.03 0.02
Tax % 0.00 0.00 25.00 40.00 0.00 0.00 0.00 0.00 0.00 16.67 25.00 0.00 0.00
Net Profit 0.12 0.11 0.03 0.02 0.04 0.78 -0.50 -0.30 0.01 0.05 0.03 -0.03 0.02
EPS in Rs 0.10 0.09 0.04 0.02 0.08 1.49 -0.95 -0.57 0.02 0.10 0.06 -0.06 0.04

Profit & Loss

Annual ยท Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Sales 8.020.810.000.000.000.170.470.150.000.261.932.43
Expenses 7.901.870.110.190.120.500.720.380.230.882.072.54
Operating Profit 0.12-1.06-0.11-0.19-0.12-0.33-0.25-0.23-0.23-0.62-0.14-0.11
OPM % 1.50-130.86โ€”โ€”โ€”-194.12-53.19-153.33โ€”-238.46-7.25-4.53
Other Income 0.161.050.200.421.980.180.000.000.00-0.720.000.00
Interest 0.000.000.000.000.000.000.000.000.010.000.000.00
Depreciation 0.000.010.010.010.010.010.010.010.000.000.000.00
Profit before tax 0.28-0.020.080.221.85-0.16-0.26-0.24-0.24-1.34-0.14-0.11
Tax % 10.710.0025.000.000.000.003.850.000.000.000.00-36.36
Net Profit 0.25-0.010.060.231.85-0.16-0.27-0.24-0.24-1.34-0.14-0.08
EPS in Rs 0.22-0.020.110.443.53-0.31-0.52-0.46-0.46-2.56-0.27-0.15
Dividend Payout % 0.000.000.000.000.000.000.000.000.000.000.000.00

Balance Sheet

Annual ยท Rs. Crores โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Equity Capital 11.585.245.245.245.245.245.245.245.245.245.245.24
Reserves 2.53-0.83-5.89-5.95-6.18-8.03-7.86-7.59-7.35-7.11-5.04-4.90
Borrowings 0.330.050.350.350.352.332.522.242.041.851.721.50
Other Liabilities 1.760.710.380.570.800.760.560.440.140.160.681.85
Total Liabilities 16.205.170.080.210.210.300.460.330.070.142.603.69
Fixed Assets 0.040.040.070.070.080.090.100.110.000.000.000.00
CWIP 0.000.000.000.000.000.000.000.000.000.000.000.00
Investments 0.000.000.000.000.000.000.000.000.000.000.010.01
Other Assets 16.165.130.010.140.130.210.360.220.070.142.593.68
Total Assets 16.205.170.080.210.210.300.460.330.070.142.603.69

Cash Flows

Annual ยท Rs. Crores โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Cash from Operating Activity -11.00-2.290.000.001.910.26-0.28-0.05-0.26-1.06-0.19-0.10
Cash from Investing Activity 0.000.000.000.000.000.000.00-0.110.000.010.000.00
Cash from Financing Activity 9.744.770.000.00-1.98-0.190.280.160.261.020.220.10
Net Cash Flow -1.262.480.000.00-0.070.070.000.000.00-0.030.030.00
Free Cash Flow -11.00-2.290.000.001.910.26-0.28-0.17-0.26-1.05-0.19-0.10
CFO/OP % -9,142.00216.00-18.000.00-1,592.00-79.00112.0022.00113.00171.00136.00127.00

Ratios

Annual ยท Days / % โ€” latest first
Metric Mar 2026Mar 2025Mar 2021Mar 2020Mar 2019Mar 2017Mar 2016Mar 2015
Debtor Days 65.08428.0985.8831.060.000.00128.6021.03
Inventory Days 50.1427.720.00250.94446.110.000.00225.44
Days Payable 84.23291.08โ€”456.251,257.22โ€”โ€”251.51
Cash Conversion Cycle 30.99164.7385.88-174.25-811.110.00128.60-5.04
Working Capital Days 587.55874.20-6,333.82-2,112.34-5,986.00-2,723.465.67-3.00
ROCE % 2.96-0.96โ€”โ€”โ€”-52.63-7.45-6.01

Shareholding Pattern

% holding โ€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Promoters 10.46 13.80 15.14 23.13 23.13 23.13 23.13 23.13 23.13 23.13 23.13 23.13
DIIs 0.00 0.00 0.00 0.00 0.00 0.15 0.15 0.15 0.15 0.15 0.15 0.15
Public 89.53 86.21 84.86 76.86 76.87 76.71 76.72 76.72 76.71 76.71 76.71 76.71
No. of Shareholders 6,865 6,802 6,815 6,764 6,729 6,756 6,657 6,291 6,252 6,251 6,252 6,250

Corporate Actions

2 records
ActionEx DateRecord DateRatioAmount (โ‚น)Notes
Other 29 Jan 2009 12 Feb 2009 โ€” โ€” Reduction of Capital
Other 29 Jan 2009 12 Feb 2009 โ€” โ€” Consolidation of Shares

Announcements

5 filings